140 related articles for article (PubMed ID: 24530269)
1. 5-HT(3) receptor expression in the mouse vestibular ganglion.
Takimoto Y; Ishida Y; Nakamura Y; Kamakura T; Yamada T; Kondo M; Kitahara T; Uno A; Imai T; Horii A; Okazaki S; Nishiike S; Inohara H; Shimada S
Brain Res; 2014 Apr; 1557():74-82. PubMed ID: 24530269
[TBL] [Abstract][Full Text] [Related]
2. Differential composition of 5-hydroxytryptamine3 receptors synthesized in the rat CNS and peripheral nervous system.
Morales M; Wang SD
J Neurosci; 2002 Aug; 22(15):6732-41. PubMed ID: 12151552
[TBL] [Abstract][Full Text] [Related]
3. Importance of recognition loops B and D in the activation of human 5-HT₃ receptors by 5-HT and meta-chlorophenylbiguanide.
Michaelson SD; Paulsen IM; Kozuska JL; Martin IL; Dunn SM
Neuropharmacology; 2013 Oct; 73():398-403. PubMed ID: 23810831
[TBL] [Abstract][Full Text] [Related]
4. Serotonin excites neurons in the human submucous plexus via 5-HT3 receptors.
Michel K; Zeller F; Langer R; Nekarda H; Kruger D; Dover TJ; Brady CA; Barnes NM; Schemann M
Gastroenterology; 2005 May; 128(5):1317-26. PubMed ID: 15887114
[TBL] [Abstract][Full Text] [Related]
5. Role of aspartate 298 in mouse 5-HT3A receptor gating and modulation by extracellular Ca2+.
Hu XQ; Lovinger DM
J Physiol; 2005 Oct; 568(Pt 2):381-96. PubMed ID: 16096341
[TBL] [Abstract][Full Text] [Related]
6. Expression of serotonin receptor genes in cranial ganglia.
Maeda N; Ohmoto M; Yamamoto K; Kurokawa A; Narukawa M; Ishimaru Y; Misaka T; Matsumoto I; Abe K
Neurosci Lett; 2016 Mar; 617():46-51. PubMed ID: 26854841
[TBL] [Abstract][Full Text] [Related]
7. Subunit-dependent inhibition and potentiation of 5-HT3 receptor by the anticancer drug, topotecan.
Nakamura Y; Ishida Y; Yamada T; Kondo M; Shimada S
J Neurochem; 2013 Apr; 125(1):7-15. PubMed ID: 23305320
[TBL] [Abstract][Full Text] [Related]
8. Expression of transient receptor potential channel mucolipin (TRPML) and polycystine (TRPP) in the mouse inner ear.
Takumida M; Anniko M
Acta Otolaryngol; 2010 Feb; 130(2):196-203. PubMed ID: 20095091
[TBL] [Abstract][Full Text] [Related]
9. Naturally occurring variations in the human 5-HT3A gene profoundly impact 5-HT3 receptor function and expression.
Krzywkowski K; Jensen AA; Connolly CN; Bräuner-Osborne H
Pharmacogenet Genomics; 2007 Apr; 17(4):255-66. PubMed ID: 17496724
[TBL] [Abstract][Full Text] [Related]
10. Conformational Changes in the 5-HT
Munro L; Ladefoged LK; Padmanathan V; Andersen S; Schiøtt B; Kristensen AS
Mol Pharmacol; 2019 Dec; 96(6):720-734. PubMed ID: 31582575
[TBL] [Abstract][Full Text] [Related]
11. Functional Expression of an Osmosensitive Cation Channel, Transient Receptor Potential Vanilloid 4, in Rat Vestibular Ganglia.
Kamakura T; Kondo M; Koyama Y; Hanada Y; Ishida Y; Nakamura Y; Yamada T; Takimoto Y; Kitahara T; Ozono Y; Horii A; Imai T; Inohara H; Shimada S
Audiol Neurootol; 2016; 21(4):268-274. PubMed ID: 27705979
[TBL] [Abstract][Full Text] [Related]
12. Investigation of 5-HT
Kojima SI; Kojima K; Fujita T
Eur J Pharmacol; 2017 Mar; 799():196-200. PubMed ID: 28189582
[TBL] [Abstract][Full Text] [Related]
13. The 5-hydroxytryptamine type 3 (5-HT3) receptor reveals a novel determinant of single-channel conductance.
Peters JA; Kelley SP; Dunlop JI; Kirkness EF; Hales TG; Lambert JJ
Biochem Soc Trans; 2004 Jun; 32(Pt3):547-52. PubMed ID: 15157181
[TBL] [Abstract][Full Text] [Related]
14. The Role of 5-HT3 Receptors in Signaling from Taste Buds to Nerves.
Larson ED; Vandenbeuch A; Voigt A; Meyerhof W; Kinnamon SC; Finger TE
J Neurosci; 2015 Dec; 35(48):15984-95. PubMed ID: 26631478
[TBL] [Abstract][Full Text] [Related]
15. Serotonin exerts a direct modulatory role on bladder afferent firing in mice.
Konthapakdee N; Grundy L; O'Donnell T; Garcia-Caraballo S; Brierley SM; Grundy D; Daly DM
J Physiol; 2019 Nov; 597(21):5247-5264. PubMed ID: 31520534
[TBL] [Abstract][Full Text] [Related]
16. Effect of chronic activation of 5-HT3 receptors on 5-HT3, 5-HT(1A) and 5-HT(2A) receptors functional activity and expression of key genes of the brain serotonin system.
Kondaurova EM; Naumenko VS; Popova NK
Neurosci Lett; 2012 Jul; 522(1):52-6. PubMed ID: 22705909
[TBL] [Abstract][Full Text] [Related]
17. SR 57227A is a partial agonist/partial antagonist of 5-HT
Nakamura Y; Kondo M; Koyama Y; Shimada S
Biochem Biophys Res Commun; 2019 Jan; 508(2):590-596. PubMed ID: 30509492
[TBL] [Abstract][Full Text] [Related]
18. Ethanol potentiation of 5-hydroxytryptamine3 receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian neurons.
Lovinger DM; White G
Mol Pharmacol; 1991 Aug; 40(2):263-70. PubMed ID: 1715016
[TBL] [Abstract][Full Text] [Related]
19. Activation of human 5-hydroxytryptamine type 3 receptors via an allosteric transmembrane site.
Lansdell SJ; Sathyaprakash C; Doward A; Millar NS
Mol Pharmacol; 2015 Jan; 87(1):87-95. PubMed ID: 25338672
[TBL] [Abstract][Full Text] [Related]
20. Delineation of the functional properties and the mechanism of action of TMPPAA, an allosteric agonist and positive allosteric modulator of 5-HT3 receptors.
Gasiorek A; Trattnig SM; Ahring PK; Kristiansen U; Frølund B; Frederiksen K; Jensen AA
Biochem Pharmacol; 2016 Jun; 110-111():92-108. PubMed ID: 27086281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
